cytolipin R
fourth glycosphingolipid of the five lipid haptens that have been isolated from animal cells; isolated from rat lymphosarcoma as specific antigen to transplanted rat tumors; structure determined to be N-acetylgalactosaminyl (beta 1 to 3)galactosyl(alpha 1 to 3)galactosyl (beta 1 to 4)glucosylceramide; from rat colon and rat adenocarcinoma
Also Known As:
isoglobotetraosylceramide
Networked: 12
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Related Diseases
1. | Neoplasms (Cancer)
12/01/1970
- " Immunochemical studies of organ and tumor lipids XVIII. Cytolipin R determinants in the rat erythrocyte membrane." 06/01/1977
- " Cytolipin R was confirmed to be not a rat tumor-dependent, but a species-specific glycolipid." 04/26/1989
- " Monoclonal antibodies produced against isoglobotetraosylceramide detected this and another novel rat tumor-associated glycolipid not present in epithelial cells nor in non-epithelial stroma of normal rat colon (Brodin, T., Thurin, J., Strömberg, N., Karlsson, K.-A. " 04/26/1989
- " Isoglobotetraosylceramide (GalNAc(beta 1-3)Gal(alpha 1-3)Gal(beta 1-4)Glc (beta 1-1)Cer), the major glycolipid species in dimethylhydrazine-induced rat tumors of colorectal origin, was not detected in epithelial cells of normal colon but was present in the non-epithelial stroma and could be extracted from each of nine tumors studied. " 11/01/1974
- " Cytolipin R and its possible precursor ceramide trisaccharide from metastatic rat mammary tumor."
|
2. | Non-Hodgkin Lymphoma (Lymphosarcoma)
|
3. | Hemolysis
|
4. | Adenocarcinoma
|
5. | Colorectal Neoplasms (Colorectal Cancer)
|
|
Related Drugs and Biologics